Abstract
We performed an observational study on 137 patients undergoing carotid endarterectomy (CEA). Patients on statins were less likely to have had symptoms in the 4 weeks before CEA (p = 0.0049) and were less likely to have spontaneous cerebral embolization detected by transcranial Doppler (p = 0.0459). Carotid plaques retrieved at CEA from patients taking statins revealed significantly lower concentrations of matrix metalloproteinase-1 (p = 0.0176), matrix metalloproteinase-9 (p = 0.0018), and interleukin-6 (p = 0.0005).
MeSH terms
-
Aged
-
Aged, 80 and over
-
Arteriosclerosis / diagnostic imaging
-
Arteriosclerosis / drug therapy*
-
Arteriosclerosis / enzymology*
-
Arteriosclerosis / pathology
-
Arteriosclerosis / surgery
-
Atorvastatin
-
Carotid Artery Diseases / blood
-
Carotid Artery Diseases / diagnostic imaging
-
Carotid Artery Diseases / drug therapy*
-
Carotid Artery Diseases / enzymology*
-
Carotid Artery Diseases / pathology
-
Carotid Artery Diseases / surgery
-
Endarterectomy, Carotid
-
Fatty Acids, Monounsaturated / administration & dosage
-
Female
-
Fluvastatin
-
Heptanoic Acids / administration & dosage
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
-
Indoles / administration & dosage
-
Interleukins / metabolism
-
Male
-
Matrix Metalloproteinases / metabolism
-
Middle Aged
-
Pravastatin / administration & dosage
-
Pyrroles / administration & dosage
-
Simvastatin / administration & dosage
-
Tissue Inhibitor of Metalloproteinases / metabolism
-
Tumor Necrosis Factor-alpha / metabolism
-
Ultrasonography
Substances
-
Fatty Acids, Monounsaturated
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Indoles
-
Interleukins
-
Pyrroles
-
Tissue Inhibitor of Metalloproteinases
-
Tumor Necrosis Factor-alpha
-
Fluvastatin
-
Atorvastatin
-
Simvastatin
-
Matrix Metalloproteinases
-
Pravastatin